GABABR activation alleviates Streptococcus equi subsp. zooepidemicus-induced acute lung injury by suppressing inflammation and oxidative stress in pulmonary macrophages via IRAK3
- 1School of Animal Science and Technology, Foshan University, Foshan, Guangdong, China
- 2Foshan University Veterinary Teaching Hospital, Foshan University, Foshan, Guangdong, China
Abstract
Streptococcus equi subsp. zooepidemicus (SEZ) infection poses a significant threat to animals and humans, causing acute lung injury driven by excessive inflammation and tissue destruction. The gamma-aminobutyric acid type B receptor (GABABR) has been implicated in modulating inflammatory responses, but its specific role in SEZ-induced acute lung injury remains unexplored. This study aimed to investigate the protective effects of pharmacological GABABR activation against SEZ-triggered pulmonary damage. Employing a mouse model of SEZ infection and MH-S alveolar macrophages, we demonstrated that pretreatment with baclofen downregulated a spectrum of pro-inflammatory mediators (CXCL9, CXCL10, GM-CSF, IL-1β, IL-6, IL-17A, and MCP-1) and counteracted oxidative stress by enhancing the NRF2/HO-1 antioxidant pathway and its downstream effectors (GPX4 and SOD) in both lung tissues and macrophages. Mechanistically, baclofen exerted its effects by elevating the expression of the negative regulator interleukin-1 receptor-associated kinase 3 (IRAK3), which in turn suppressed the NLRP3/caspase-1/gasdermin D (GSDMD) inflammatory axis. Due to the suppression of inflammation and oxidative stress, the pulmonary epithelial barrier was restored in infected mice, as evidenced by the upregulation of tight junction proteins (Claudin-1, Claudin-2, Occludin, and ZO-1) in the lung. These effects collectively markedly attenuated lung histopathological injury, reduced inflammatory cell infiltration, and restored goblet cell morphology and mucin secretion. Conversely, IRAK3 deficiency exacerbated SEZ-induced lung injury, barrier disruption, oxidative stress, and NLRP3/caspase-1/GSDMD pathway activation. Collectively, our findings establish that GABABR activation protects against SEZ-induced acute lung injury by enhancing barrier integrity, reprogramming macrophage antioxidant responses, and inhibiting inflammatory signaling through an IRAK3-dependent mechanism, identifying GABABR as a promising therapeutic target for bacterial pneumonia.
IMPORTANCE: Streptococcus equi subsp. zooepidemicus (SEZ) is a major zoonotic pathogen responsible for severe animal outbreaks and occasional life-threatening human infections, creating an urgent need for effective interventions. Gamma-aminobutyric acid type B receptor (GABABR) represents a promising immunomodulatory target, as it is known to help limit inflammation during bacterial infections. In this study, we demonstrate that activating GABABR pharmacologically protects against SEZ-induced acute lung injury by increasing interleukin-1 receptor-associated kinase 3 (IRAK3) expression in macrophages. This elevation of IRAK3 serves a dual function, suppressing the NLRP3/caspase-1/gasdermin D pathway while also strengthening antioxidant defenses and epithelial barrier integrity. Further support for this mechanism comes from the observation that IRAK3 deletion leads to exacerbated tissue injury. Taken together, these findings reveal a previously unrecognized GABABR-IRAK3 regulatory axis that plays a central role in SEZ pathogenesis, highlighting a promising host-directed target for therapeutic development.
Related
- 4-Octyl itaconate ameliorates cigarette smoke-induced chronic obstructive pulmonary disease by suppressing necroptosis in alveolar macrophages via Nrf2 activation
- Periprosthetic Joint Infection Caused by Streptococcus equi Subspecies zooepidemicus: The First Reported Case Confirmed by Synovial Fluid Culture.
- Valacyclovir reduces inflammation and IgG subclass activation by suppressing herpesvirus reactivation in antarctic expeditioners
- Atractylenolide III attenuates age-related vertebral bone loss by suppressing macrophage inflammation and osteoclastogenesis
- Nervonic Acid Promotes Skin Regeneration by Enhancing Collagen Synthesis and Suppressing Inflammation
BibTeX
@article{deng2026gababr,
title = {{GABABR activation alleviates Streptococcus equi subsp. zooepidemicus-induced acute lung injury by suppressing inflammation and oxidative stress in pulmonary macrophages via IRAK3}},
author = {Ziteng Deng and Huilin Liu and Yijiang Yang and Wenshu Yi and Deding Wu and Xiaoqing Cheng and Anqi Lu and Yiran Chen and Yajuan Li and Yaqiong Ye and Jiedan Liao and Yunfei Huang and Qiang Fu},
journal = {Microbiology Spectrum},
year = {2026},
month = oct,
doi = {10.1128/spectrum.01040-26},
url = {https://doi.org/10.1128/spectrum.01040-26},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - GABABR activation alleviates Streptococcus equi subsp. zooepidemicus-induced acute lung injury by suppressing inflammation and oxidative stress in pulmonary macrophages via IRAK3
AU - Ziteng Deng
AU - Huilin Liu
AU - Yijiang Yang
AU - Wenshu Yi
AU - Deding Wu
AU - Xiaoqing Cheng
AU - Anqi Lu
AU - Yiran Chen
AU - Yajuan Li
AU - Yaqiong Ye
AU - Jiedan Liao
AU - Yunfei Huang
AU - Qiang Fu
PY - 2026
DA - 2026/10/06
JO - Microbiology Spectrum
DO - 10.1128/spectrum.01040-26
UR - https://doi.org/10.1128/spectrum.01040-26
AB - Streptococcus equi subsp. zooepidemicus (SEZ) infection poses a significant threat to animals and humans, causing acute lung injury driven by excessive inflammation and tissue destruction. The gamma-aminobutyric acid type B receptor (GABABR) has been implicated in modulating inflammatory responses, but its specific role in SEZ-induced acute lung injury remains unexplored. This study aimed to investigate the protective effects of pharmacological GABABR activation against SEZ-triggered pulmonary damage. Employing a mouse model of SEZ infection and MH-S alveolar macrophages, we demonstrated that pretreatment with baclofen downregulated a spectrum of pro-inflammatory mediators (CXCL9, CXCL10, GM-CSF, IL-1β, IL-6, IL-17A, and MCP-1) and counteracted oxidative stress by enhancing the NRF2/HO-1 antioxidant pathway and its downstream effectors (GPX4 and SOD) in both lung tissues and macrophages. Mechanistically, baclofen exerted its effects by elevating the expression of the negative regulator interleukin-1 receptor-associated kinase 3 (IRAK3), which in turn suppressed the NLRP3/caspase-1/gasdermin D (GSDMD) inflammatory axis. Due to the suppression of inflammation and oxidative stress, the pulmonary epithelial barrier was restored in infected mice, as evidenced by the upregulation of tight junction proteins (Claudin-1, Claudin-2, Occludin, and ZO-1) in the lung. These effects collectively markedly attenuated lung histopathological injury, reduced inflammatory cell infiltration, and restored goblet cell morphology and mucin secretion. Conversely, IRAK3 deficiency exacerbated SEZ-induced lung injury, barrier disruption, oxidative stress, and NLRP3/caspase-1/GSDMD pathway activation. Collectively, our findings establish that GABABR activation protects against SEZ-induced acute lung injury by enhancing barrier integrity, reprogramming macrophage antioxidant responses, and inhibiting inflammatory signaling through an IRAK3-dependent mechanism, identifying GABABR as a promising therapeutic target for bacterial pneumonia. IMPORTANCE: Streptococcus equi subsp. zooepidemicus (SEZ) is a major zoonotic pathogen responsible for severe animal outbreaks and occasional life-threatening human infections, creating an urgent need for effective interventions. Gamma-aminobutyric acid type B receptor (GABABR) represents a promising immunomodulatory target, as it is known to help limit inflammation during bacterial infections. In this study, we demonstrate that activating GABABR pharmacologically protects against SEZ-induced acute lung injury by increasing interleukin-1 receptor-associated kinase 3 (IRAK3) expression in macrophages. This elevation of IRAK3 serves a dual function, suppressing the NLRP3/caspase-1/gasdermin D pathway while also strengthening antioxidant defenses and epithelial barrier integrity. Further support for this mechanism comes from the observation that IRAK3 deletion leads to exacerbated tissue injury. Taken together, these findings reveal a previously unrecognized GABABR-IRAK3 regulatory axis that plays a central role in SEZ pathogenesis, highlighting a promising host-directed target for therapeutic development.
SN - 2165-0497
ER -